• Home Ines Ibanez-Tallon the Max Delbr ck Center for Molecular Medicine Berlin-Buch.

Ines Ibanez-Tallon the Max Delbr ck Center for Molecular Medicine Berlin-Buch.

The FAME study showed that of a patient of a patient or having a heart attack was reduced by approximately 35 % when FFR measurement was performed. The study also revealed that the 12-month total rate of major adverse cardiac events was 28 percent lower for the FFR guided group likelihood of a patient likelihood of a patient decreases with the further for the treatment back www.zyprexa-lawyer.com .

In January, Affymax announced the completion of treatment and follow-up of patients enrolled in the four – trial, Phase 3 clinical program for Hematide in the U.S. The company expects top-line results top-line results from these studies in the second quarter of 2010. And Japan clinical program enrolled approximately 2,600 patients with chronic kidney disease at approximately 400 study centers.

Ines Ibanez-Tallon the Max Delbr ck Center for Molecular Medicine Berlin-Buch, Germany? to study function of ion channels in neurons. Ion channels in the cell membranes provide cells communicating with its surroundings and be therefore critical. That the MDC system allowing system that allows for the first time the specific, long-lasting study ion channel function in mammals and well as the blocking the ion channels having neurotoxins. Transgenic mice they succeeded in blocking the chronic pain the introduction of a toxin gene into the organism (Nature Method, doi: 10.1038/NMETH.